IBN SINA Pharmaceutical Industry Balance Sheet Health
Financial Health criteria checks 5/6
IBN SINA Pharmaceutical Industry has a total shareholder equity of BDT3.4B and total debt of BDT1.5B, which brings its debt-to-equity ratio to 45.8%. Its total assets and total liabilities are BDT6.2B and BDT2.8B respectively. IBN SINA Pharmaceutical Industry's EBIT is BDT952.9M making its interest coverage ratio 20.8. It has cash and short-term investments of BDT495.9M.
Key information
45.8%
Debt to equity ratio
৳1.54b
Debt
| Interest coverage ratio | 20.8x |
| Cash | ৳495.93m |
| Equity | ৳3.37b |
| Total liabilities | ৳2.83b |
| Total assets | ৳6.20b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: IBNSINA's short term assets (BDT2.4B) exceed its short term liabilities (BDT2.3B).
Long Term Liabilities: IBNSINA's short term assets (BDT2.4B) exceed its long term liabilities (BDT570.9M).
Debt to Equity History and Analysis
Debt Level: IBNSINA's net debt to equity ratio (31.1%) is considered satisfactory.
Reducing Debt: IBNSINA's debt to equity ratio has increased from 41.8% to 45.8% over the past 5 years.
Debt Coverage: IBNSINA's debt is well covered by operating cash flow (52.8%).
Interest Coverage: IBNSINA's interest payments on its debt are well covered by EBIT (20.8x coverage).